
Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Free Report) – Analysts at Zacks Research lowered their FY2026 EPS estimates for shares of Baird Medical Investment in a research report issued to clients and investors on Thursday, September 10th. Zacks Research analyst T. Kerr now forecasts that the company will post earnings of $0.08 per share for the year, down from their prior estimate of $0.10. The consensus estimate for Baird Medical Investment’s current full-year earnings is $0.10 per share.
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Baird Medical Investment in a report on Wednesday, August 5th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.
Baird Medical Investment Stock Performance
Shares of BDMD opened at $1.06 on Wednesday. Baird Medical Investment has a 1 year low of $0.76 and a 1 year high of $3.70. The stock’s fifty day moving average price is $1.11 and its two-hundred day moving average price is $1.52.
Hedge Funds Weigh In On Baird Medical Investment
A hedge fund recently bought a new stake in Baird Medical Investment stock. Citadel Advisors LLC bought a new position in Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 54,895 shares of the company’s stock, valued at approximately $63,000. Citadel Advisors LLC owned approximately 0.13% of Baird Medical Investment as of its most recent filing with the Securities & Exchange Commission. 19.78% of the stock is owned by institutional investors.
About Baird Medical Investment
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Read More
- Five stocks we like better than Baird Medical Investment
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Baird Medical Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baird Medical Investment and related companies with MarketBeat.com's FREE daily email newsletter.
